12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga · 04/15 12:08
Gainers
- Mural Oncology (NASDAQ:MURA) shares increased by 31.1% to $1.35 during Tuesday's pre-market session. The company's market cap stands at $23.2 million.
- Ensysce Biosciences (NASDAQ:ENSC) stock rose 20.36% to $2.36. The company's market cap stands at $3.3 million.
- OneMedNet (NASDAQ:ONMD) shares rose 17.36% to $0.58. The market value of their outstanding shares is at $16.2 million.
- Fractyl Health (NASDAQ:GUTS) stock rose 15.61% to $1.15. The company's market cap stands at $55.3 million.
- MetaVia (NASDAQ:MTVA) shares increased by 14.13% to $2.1. The company's market cap stands at $18.1 million.
- Precision BioSciences (NASDAQ:DTIL) shares increased by 12.73% to $5.03. The company's market cap stands at $52.7 million.
Losers
- Elutia (NASDAQ:ELUT) shares fell 54.7% to $0.91 during Tuesday's pre-market session. The market value of their outstanding shares is at $37.1 million.
- Geovax Labs (NASDAQ:GOVX) shares decreased by 29.92% to $0.75. The company's market cap stands at $7.0 million.
- Spruce Biosciences (NASDAQ:SPRB) stock fell 23.35% to $0.24. The company's market cap stands at $9.9 million.
- Nexalin Technology (NASDAQ:NXL) stock fell 21.34% to $1.4. The market value of their outstanding shares is at $18.6 million.
- Longevity Health Holdings (NASDAQ:XAGE) shares decreased by 21.03% to $0.16. The market value of their outstanding shares is at $4.8 million.
- Sophia Genetics (NASDAQ:SOPH) stock decreased by 20.42% to $2.3. The company's market cap stands at $152.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.